No distinct dose adjustment encouraged when tofacitinib coadministered with powerful CYP2C19 inhibitors; reduce tofacitinib dose if coadministered with both reasonable CYP3A4 and powerful CYP2C19 inhibitors . Indicated to further improve wakefulness in Grown ups with extreme sleepiness linked to